Scienture Holdings, Inc. Common Stock SCNX
Analyst Ratings
- Consensus
- Buy — 1 Buy · 0 Hold · 0 Sell (1 analysts)
- Avg. Price Target
- $1.50 (-63.9% downside)
Key Stats
- Today's Range
- $3.65 – $4.20
- 50-Day Range
- $3.23 – $12.02
- 52-Week Range
- $3.23 – $65.00
- Volume
- 93K shs
- Average Volume
- 283K shs
- Market Cap
- $6.18 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.38%
- Days to Cover
- 1.00
About Scienture Holdings, Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
Related Stocks
Compare head-to-head: SCNX vs LLY·SCNX vs JNJ·SCNX vs ABBV·SCNX vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.